Prof. Dr. Leopold Schmetterer graduated from the Technical University of Vienna and obtained his Ph.D. in 1989. He is currently the Scientific Director and Head of Ocular Imaging at the SingaporeEye Research Institute, as well as a professor in the Department of Biomedical Engineering, Nanyang Technological University. He is also the PI of the SERI-NTU Advanced Ocular Engineering (STANCE) program, leading a team of researchers in developing ocular imaging systems. Until August 2016, he chaired the Ophthalmic Pharmacology team at the Department of Clinical Pharmacology of the Medical University of Vienna. He previously held a post-doctoral position at the Institute de Recherche en Ophthalmologie in Sion and was a guest professor at EPFL in Lausanne. His current research interests include the development of novel technology and applications in preclinical research and clinics. He is also interested in clinical trials and
involved in many studies in retina, glaucoma, cornea and dry eye. Prof. Dr. Schmetterer has received a number of awards and honors, such as becoming a Gold Fellow of the Association for Research in Vision and Ophthalmology (ARVO) in 2019, as well as earning the Gold Medal from Acta Ophthalmoologica in 2017 and the Hans Goldmann Medal in 2015.
Prof. Dr. Leopold Schmetterer graduated from the Technical University of Vienna and obtained his Ph.D. in 1989. He is currently the Scientific Director and Head of Ocular Imaging at the SingaporeEye Research Institute, as well as a professor in the Department of Biomedical Engineering, Nanyang Technological University. He is also the PI of the SERI-NTU Advanced Ocular Engineering (STANCE) program, leading a team of researchers in developing ocular imaging systems. Until August 2016, he chaired the Ophthalmic Pharmacology team at the Department of Clinical Pharmacology of the Medical University of Vienna. He previously held a post-doctoral position at the Institute de Recherche en Ophthalmologie in Sion and was a guest professor at EPFL in Lausanne. His current research interests include the development of novel technology and applications in preclinical research and clinics. He is also interested in clinical trials and
involved in many studies in retina, glaucoma, cornea and dry eye. Prof. Dr. Schmetterer has received a number of awards and honors, such as becoming a Gold Fellow of the Association for Research in Vision and Ophthalmology (ARVO) in 2019, as well as earning the Gold Medal from Acta Ophthalmoologica in 2017 and the Hans Goldmann Medal in 2015.